Lipodystrophy associated with protease inhibitors

British Journal of Dermatology

Volumn 142, Issue 3, 2000, Pages 496-500

  Panse, I ^a   Vasseur, E ^a   Raffin Sanson, M L ^a   Staroz, F ^a   Rouveix, E ^a   Saiag, Philippe ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Adverse drug reaction; Human immunodeficiency virus; Lipodystrophy; Protease inhibitor

Indexed keywords

NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID STORAGE; LIPOATROPHY; LIPODYSTROPHY; MALE; OBESITY; PARONYCHIA; PRIORITY JOURNAL; SUBCUTANEOUS FAT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FACIES; HIV-1; HUMANS; HYPERTRIGLYCERIDEMIA; LIPODYSTROPHY; MALE; MIDDLE AGED; PARONYCHIA; PROTEASE INHIBITORS;

EID: 0002981434     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03363.x     Document Type: Article

References (21)

1. 1 Dube MP, Johnson DL, Currier JS et al. Protease inhibitor-associated hyperglycaemia. (Letter.) Lancet 1997; 350: 713-14.
2. 2 Walli R, Herfort O, Michl G et al. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1 -infected patients. AIDS 1998; 12: 167-73.
3. 3 Herry I, Bernard L, de Truchis P, Perronne C. Hypertrophy of the breasts in a patient treated with indinavir. Clin Infect Dis 1997; 25: 937-8.
4. 4 Lo JC, Mulligan K, Tai VW et al. 'Buffalo hump' in men with HIV-1 infection. Lancet 1998; 351: 867-70.
5. 5 Viraben R, Aquinila C. Indinavir-associated lipodystrophy. AIDS 1998; 12: F37-9.
6. 6 Carr A, Samaras K, Burton S et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving protease inhibitors. AIDS 1998; 12: F51-8.
7. 7 Sobey WJ, Beer SF, Carrington CA. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin. 65-66 split and 32-33 split proinsulins. Biochem J 1989; 260: 535-41.
8. 8 Raffin-Sanson ML, Raux-Demay MC, Massias JF et al. Plasma proopiomelanocortin characterizes the aggressivity of ACTH-secreting tumors. J Clin Endocrinol Metab 1996; 81: 4272-7.
9. 9 Smas CM, Sul HS. Control of adipocyte differentiation. Biochem J 1995; 309: 697-710.
10. 10 Black MM, Cunliffe WJ. Subcutaneous fat. In: Textbook of Dermatology (Champion RH, Burton JL, Burns DA, Breathnach SM, eds), 6th edn, Vol. 3. Oxford: Blackwell Science, 1998: 2403-35.
11. 11 Smevik B, Swensen T, Kolbenstvedt A, Trygslad O. Computed tomography and ultrasonography of the abdomen in congenital generalized lipodystrophy. Radiology 1982; 142: 687-9.
12. 12 Garg A, Peshock RM, Fleckenstein JL. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunningan variety). J Clin Endocrinol Metab 1999; 84: 170-4.
13. 13 Miller KD, Jones E, Yanovsky JA et al. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998; 351: 871-5.
14. 14 Elwood W. Lipodystrophy: cause for concern with protease inhibitor therapy? Reactions 1998; 713: 3-4.
15. 15 De Luca A, Murri R, Damiano F et al. Buffalo hump in HIV-1 infection. (Letter.) Lancet 1998; 352: 320.
16. 16 Henry K, Melroe H, Huebsch J et al. Severe premature coronary artery disease with protease inhibitors. (Letter.) Lancet 1998; 351: 1328.
17. 17 Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 1998; 352: 1881-3.
18. 18 Bouscarat F, Bouchard C, Bouhour D. Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir, (Letter.) N Engl J Med 1998; 338: 1776-7.
19. 19 Baran R. Etretinate and the nails (study of 130 cases): possible mechanisms of some side-effects. Clin Exp Dermatol 1986; 2: 148-52.
20. 20 Aldeen T, Wells C, Hay P et al. Lipodystrophy associated with nevirapine-containing antiretroviral therapies. AIDS 1999; 13: 865-7.
21. 21 Gervasoni C, Ridolfo AL, Trifiro G et al. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS 1999; 13: 465-71.